These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The histamine H₄ receptor: targeting inflammatory disorders. Walter M; Kottke T; Stark H Eur J Pharmacol; 2011 Oct; 668(1-2):1-5. PubMed ID: 21741967 [TBL] [Abstract][Full Text] [Related]
23. The histamine H3 receptor as a therapeutic drug target for CNS disorders. Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511 [TBL] [Abstract][Full Text] [Related]
24. Histamine H4 receptor ligands and their potential therapeutic applications: an update. Kiss R; Keserű GM Expert Opin Ther Pat; 2012 Mar; 22(3):205-21. PubMed ID: 22385042 [TBL] [Abstract][Full Text] [Related]
25. Ligand based design of novel histamine H₄ receptor antagonists; fragment optimization and analysis of binding kinetics. Smits RA; Lim HD; van der Meer T; Kuhne S; Bessembinder K; Zuiderveld OP; Wijtmans M; de Esch IJ; Leurs R Bioorg Med Chem Lett; 2012 Jan; 22(1):461-7. PubMed ID: 22153663 [TBL] [Abstract][Full Text] [Related]
27. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening. Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760 [TBL] [Abstract][Full Text] [Related]
28. Molecular aspects of the histamine H3 receptor. Bongers G; Bakker RA; Leurs R Biochem Pharmacol; 2007 Apr; 73(8):1195-204. PubMed ID: 17276412 [TBL] [Abstract][Full Text] [Related]
29. First metal-containing histamine H3 receptor ligands. Sander K; Kottke T; Hoffend C; Walter M; Weizel L; Camelin JC; Ligneau X; Schneider EH; Seifert R; Schwartz JC; Stark H Org Lett; 2010 Jun; 12(11):2578-81. PubMed ID: 20446742 [TBL] [Abstract][Full Text] [Related]
30. A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H3 receptor: effect of various substitutions at the primary amino function. Govoni M; Lim HD; El-Atmioui D; Menge WM; Timmerman H; Bakker RA; Leurs R; De Esch IJ J Med Chem; 2006 Apr; 49(8):2549-57. PubMed ID: 16610798 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and structural and pharmacological properties of cyclopropane-based conformationally restricted analogs of 4-methylhistamine as histamine H3/H4 receptor ligands. Kobayashi T; Watanabe M; Yoshida A; Yamada S; Ito M; Abe H; Ito Y; Arisawa M; Shuto S Bioorg Med Chem; 2010 Feb; 18(3):1076-82. PubMed ID: 20045649 [TBL] [Abstract][Full Text] [Related]
32. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists. Lorenzi S; Mor M; Bordi F; Rivara S; Rivara M; Morini G; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV Bioorg Med Chem; 2005 Oct; 13(19):5647-57. PubMed ID: 16085419 [TBL] [Abstract][Full Text] [Related]
33. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027 [TBL] [Abstract][Full Text] [Related]
34. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists. Zaragoza F; Stephensen H; Peschke B; Rimvall K J Med Chem; 2005 Jan; 48(1):306-11. PubMed ID: 15634025 [TBL] [Abstract][Full Text] [Related]
35. Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity. Wijtmans M; de Graaf C; de Kloe G; Istyastono EP; Smit J; Lim H; Boonnak R; Nijmeijer S; Smits RA; Jongejan A; Zuiderveld O; de Esch IJ; Leurs R J Med Chem; 2011 Mar; 54(6):1693-703. PubMed ID: 21348462 [TBL] [Abstract][Full Text] [Related]
36. [News of the old histamine. I. A widening of the receptor family]. Stark H; Schlegel B; Sippl W Pharm Unserer Zeit; 2003; 32(2):92-3. PubMed ID: 12677959 [No Abstract] [Full Text] [Related]